Statistics for Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Patients With Neovascular Age-Related Macular Degeneration: Studies in Japan and the United States
Total visits
| views | |
|---|---|
| Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Patients With Neovascular Age-Related Macular Degeneration: Studies in Japan and the United States | 168 |
Total visits per month
| views | |
|---|---|
| May 2024 | 1 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
File Visits
| views | |
|---|---|
| Kunimoto_2019_evaluation.pdf | 275 |
Top country views
| views | |
|---|---|
| United States | 129 |
| Germany | 6 |
| Ukraine | 3 |
| Canada | 2 |
| China | 2 |
| Russia | 2 |
| Czechia | 1 |
| United Kingdom | 1 |
| India | 1 |
| Malaysia | 1 |
| Pakistan | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 50 |
| Houston | 17 |
| Fairfield | 16 |
| Ann Arbor | 8 |
| Cambridge | 8 |
| Jacksonville | 5 |
| Kiev | 3 |
| Kiez | 3 |
| San Francisco | 2 |
| Toronto | 2 |
| Arnsberg | 1 |
| Beijing | 1 |
| Chicago | 1 |
| Clayton | 1 |
| Gunzenhausen | 1 |
| Islamabad | 1 |
| Moscow | 1 |
| Nürnberg | 1 |
| Pune | 1 |
| Saint Petersburg | 1 |
| Seattle | 1 |
| Seremban | 1 |
| Shenzhen | 1 |
| Slapanice | 1 |
| Washington | 1 |